Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term morbidity. Found 26 abstracts

no pagination
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol. 2018 May;199(5):1238-44.
Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does Partial Nephrectomy Result in a Durable Overall Survival Benefit in the Medicare Population?. J Urol. 2012 Dec;188(6):2089-94.   PMCID: PMC 3815608
Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, Wong YN, Weeks JC, Niland JC, Edge SB. The Impact of Breast Reconstruction on the Delivery of Chemotherapy. Cancer. 2010 Apr;116(7):1791-800.   PMCID: PMC2847068 [Available on 2011/4/1]
Morris DE, Emami B, Mauch PM, Konski AA, Tao ML, Ng AK, Klein EA, Mohideen N, Hurwitz MD, Fraas BA, Roach M, Gore EM, Tepper JE. Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An astro outcomes initiative. International Journal of Radiation Oncology Biology Physics. 2005 May;62(1):3-19.
Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringden O, Barrett AJ. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biology of Blood and Marrow Transplantation. 2005 Dec;11(12):1006-13.
Katz ML, Ruzek SB, Miller SM, Legos P. Gender differences in patients needs and concerns to diagnostic tests for possible cancer. Journal of Cancer Education. 2004 Jan;19(4):227-31.
DuHamel KN, Smith MY, Vickberg SM, Papadopoulos E, Ostroff J, Winkel G, Manne S, Redd WH. Trauma symptoms in bone marrow transplant survivors: The role of nonmedical life events. Journal of Traumatic Stress. 2001 Jan;14(1):95-113.
Lattanzi J, McNeeley S, Hanlon A, Schultheiss TE, Hanks GE. Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. Urology. 2000 Jan;55(1):73-8.
Michalski JM, Purdy JA, Winter K, Roach M, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. International Journal of Radiation Oncology Biology Physics. 2000 Jan 15;46(2):391-402.
Hanks GE. Progress in 3D conformal radiation treatment of prostate cancer. Acta Oncologica. 1999 Jan;38:69-74.
Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: A predictor for late radiation morbidity. International Journal of Radiation Oncology Biology Physics. 1999 Feb;43(3):475-9.
Meropol NJ, Rustum YM, Creaven PJ, Blumenson LE, Frank C. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: A potential role for growth factor as mucosal protectant. Cancer Investigation. 1999 Jan;17(1):1-9.
Horwitz EM, Hanlon AL, Hanks GE. Update on the treatment of prostate cancer with external beam irradiation. The Prostate. 1998 Nov;37(3):195-206.
Lattanzi J, McNeely S, Hanlon A, Das I, Schultheiss TE, Hanks GE. Daily CT localization for correcting portal errors in the treatment of prostate cancer. International Journal of Radiation Oncology Biology Physics. 1998 Jul 15;41(5):1079-86.
Corn BW, Shaktman BD, Lanciano RM, Hogan WM, Cater JR, Anderson L, Heller P, Hernandez E. Intra- and perioperative complications associated with tandem and colpostat application for cervix cancer. Gynecologic Oncology. 1997 Feb;64(2):224-9.
Hanks GE, Schultheiss TE, Hanlon AL, Hunt M, Lee WR, Epstein BE, Coia LR. Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. International Journal of Radiation Oncology Biology Physics. 1997 Feb;37(3):543-50.
Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. International Journal of Radiation Oncology Biology Physics. 1997 Jan;37(1):3-11.
Bonin SR, Lanciano RM, Corn BW, Hogan WM, Hartz WH, Hanks GE. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. International Journal of Radiation Oncology Biology Physics. 1996 Jan;34(1):167-72.
Hanks GE. Long-term control of prostate cancer with radiation - Past, present, and future. Urologic Clinics of North America. 1996 Nov;23(4):605-&.
Hanks GE, Lee WR, Hanlon AL, Hunt M, Kaplan E, Epstein BE, Movsas B, Schultheiss TE. Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >=10 ng/ml. International Journal of Radiation Oncology Biology Physics. 1996 Jul 15;35(5):861-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term morbidity

morbidity radiotherapy prostate cancer carcinoma therapy dose-escalation complications radiation-therapy patterns adenocarcinoma conformal radiotherapy optimization radiation antigen mortality bone marrow transplantation bladder quality-of-life rectum care cancer oncology group toxicity movement recovery markers dose escalation survival irradiation uterine cervix prostate-cancer motion masses breast-cancer ultrasound prognosis radical nephrectomy ABO blood groups multileaf collimator randomized-trial stem-cell transplantation information oncology quality assurance parents diabetes communication tumor-control escalation GVHD ultrasonography three-dimensional radiotherapy experience treatment 5-fluorouracil positive life events 3DCRT GM-CSF postoperative irradiation negative life events coping style external-beam radiation radiation therapy chronic kidney-disease ptsd survivors acceptance aplasia late morbidity engraftment lymph node excision conformal treatment 3D conformal radiation therapy women organ motion squamous cell ml versus-host-disease diarrhea chemotherapy posttraumatic-stress-disorder breast cancer breast reconstruction-chemotherapy-NCCN dose-volume histograms lymphangiogram damage modulated radiation-therapy biochemical-evidence patient conformal radiation-therapy immediate reconstruction stress disorder (PTSD) recurrence framework stage iib cervical cancer external colposcopy calcium leucovorin gynecologic brachytherapy outcomes external-beam radiotherapy penile neoplasms renal cell carcinoma-nephrectomy-survival-risk assessment immobilization time androgen deprivation perforation renal-cell carcinoma local- iliac lymph nodes ib neutropenia posttraumatic prostate fluorouracil granulocyte-macrophage colony-stimulating risk-factors metastasis impact external-beam irradiation dose response psychosocial outcomes management ng mastectomy trends predictors trial acute toxicity factor determinants pelvic radiotherapy local-control advanced colorectal-cancer tandems intrauterine mucosal toxicity control cells prostatectomy prostate neoplasms oral mucositis adjuvant chemotherapy donor systematic review radical rtog bone-marrow transplantation gynecologic colony-stimulating factor
Last updated on Wednesday, March 04, 2020